Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2019, Vol. 33 ›› Issue (2): 26-30.doi: 10.6040/j.issn.1673-3770.1.2019.010

• Invited Review • Previous Articles     Next Articles

Progress in the comprehensive treatment for nasopharyngeal carcinoma

Haijun LU*(),Ji LIU,Xiao DING   

  1. Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong, China
  • Received:2019-02-20 Online:2019-03-20 Published:2019-03-28
  • Contact: Haijun LU E-mail:lhj82920608@163.com

RichHTML

49

PDF (PC)

694

Abstract:

Nasopharyngeal carcinoma is a distinct type of head and neck cancer that is common in South China, especially Guangdong and Guangxi. Because of the anatomical limitations of nasopharyngeal carcinoma and its sensitivity to radiotherapy, radiotherapy is the main treatment, although radiotherapy has certain limitations. Therefore, treatment for nasopharyngeal carcinoma includes radiotherapy combined with surgical treatment, chemotherapy, targeted therapy, and other comprehensive treatments.

Key words: Nasopharyngeal neoplasms, Surgical procedures, operative, Radiotherapy, Chemotherapy, Targeted therapy

CLC Number: 

  • R739.6
1 Al-Sarraf M , LeBlanc M , Giri PG , et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase Ⅲ randomized Intergroup study 0099[J]. J Clin Oncol, 1998, 16 (4): 1310- 1317.
doi: 10.1200/JCO.1998.16.4.1310
2 Wee J , Tan EH , Tai BC , et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage Ⅲ and Ⅳ nasopharyngeal cancer of the endemic variety[J]. J Clin Oncol, 2005, 23 (27): 6730- 6738.
doi: 10.1200/JCO.2005.16.790
3 Lee AW , Tung SY , Chua DT , et al. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma[J]. J Natl Cancer Inst, 2010, 102 (15): 1188- 98.
doi: 10.1093/jnci/djq258
4 Bian ZM , Elner VM , Lukacs NW , et al. Glycated human serum albumin induces IL-8 and MCP-1 gene expression in human corneal keratocytes[J]. Curr Eye Res, 1998, 17 (1): 65- 72.
doi: 10.1076/ceyr.17.1.65.5253
5 Motzer RJ , Agarwal N , Beard C , et al. NCCN clinical practice guidelines in oncology: kidney cancer[J]. J Natl Compr Canc Netw, 2009, 4 (8): 350- 391.
6 Chan ATC, Gregoire V, Lefebvre JL, et al. Nasopharyngeal cancer: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Annals of Oncology, 2012, 23(suppl 7):vii83-vii85. doi:10.1093/annonc/mds266.
7 Lang JY , Gao L , Guo Y , et al. Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013[J]. Future Oncol, 2014, 10 (9): 1635- 1648.
doi: 10.2217/fon.14.44
8 Chen L , Hu CS , Chen XZ , et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial[J]. Lancet Oncol, 2012, 13 (2): 163- 171.
doi: 10.1016/S1470-2045(11)70320-5
9 Tan TH , Soon YY , Cheo T , et al. Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis[J]. Radiother Oncol, 2018, 129 (1): 10- 17.
doi: 10.1016/j.radonc.2018.02.027
10 Hui EP , Ma BB , Leung SF , et al. Randomized phase Ⅱ trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma[J]. J Clin Oncol, 2009, 27 (2): 242- 249.
doi: 10.1200/JCO.2008.18.1545
11 Chen YP , Wang ZX , Chen L , et al. A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma[J]. Ann Oncol, 2015, 26 (1): 205- 211.
doi: 10.1093/annonc/mdu507
12 OuYang PY , Xie C , Mao YP , et al. Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials[J]. Ann Oncol, 2013, 24 (8): 2136- 2146.
doi: 10.1093/annonc/mdt146
13 Cao SM , Yang Q , Guo L , et al. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase Ⅲ multicentre randomised controlled trial[J]. Eur J Cancer, 2017, 75: 14- 23.
doi: 10.1016/j.ejca.2016.12.039
14 Du CR , Ying HM , Zhou JJ , et al. Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma[J]. Int J Clin Oncol, 2013, 18 (3): 464- 471.
doi: 10.1007/s10147-012-0403-y
15 Kong L , Zhang YW , Hu CS , et al. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage Ⅲ or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials[J]. Cancer, 2017, 123 (12): 2258- 2267.
doi: 10.1002/cncr.30566
16 Sun Y , Li WF , Chen NY , et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial[J]. Lancet Oncol, 2016, 17 (11): 1509- 1520.
doi: 10.1016/S1470-2045(16)30410-7
17 Wu MY , He XY , Hu CS . Intensity-modulated radiotherapy combined with sequential cisplatin and fluorouracil chemotherapy for locoregionally advanced nasopharyngeal carcinoma[J]. Medicine (Baltimore), 2018, 97 (50): e13361.
doi: 10.1097/MD.0000000000013361
18 Chen YP , Guo R , Liu N , et al. Efficacy of the additional neoadjuvant chemotherapy to concurrent chemoradiotherapy for patients with locoregionally advanced nasopharyngeal carcinoma: a bayesian network meta-analysis of randomized controlled trials[J]. J Cancer, 2015, 6 (9): 883- 892.
doi: 10.7150/jca.11814
19 Ooft ML , Braunius WW , Heus P , et al. Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysis[J]. Biomark Med, 2015, 9 (10): 997- 1010.
doi: 10.2217/bmm.15.68
20 Huang JF , Yuan XP , Pang QF , et al. Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells[J]. DDDT, 2018, 12: 2223- 2231.
doi: 10.2147/dddt.s163595
21 Huang Y , Qiu QH . Endoscopic surgery for early-stage nasopharyngeal carcinoma: a justified initial option[J]. Acta Otolaryngol, 2017, 137 (11): 1194- 1198.
doi: 10.1080/00016489.2017.1351041
22 Si YF, Lan GP, Deng ZX, et al. Influence of endoscopic sinus surgery on the quality of life of patients with early nasopharyngeal carcinoma and the analysis of prognosis-related factors[J]. Tumour Biol, 2017, 39(7):1010428317707435. doi:10.1177/1010428317707435.
23 Sun J , Huang ZY , Hu ZY , et al. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database[J]. J Transl Med, 2017, 15 (1): 116.
doi: 10.1186/s12967-017-1204-x
[1] Yan JIANG. Recurrence of nasopharyngeal carcinoma and application of endoscopic surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 1-11.
[2] Dongping CHEN,Zhihuan YANG,Yan ZHANG,Nan FANG,Bin QI. Status of surgical treatment for recurrent nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 12-16.
[3] Qianhui QIU,Zhuo CHEN. Endoscopic surgery for the treatment of locally advanced nasopharyngeal carcinoma and serious complications after radiotherapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 17-20.
[4] Zhenlin WANG,Junqi LIU. Protection of the internal carotid artery during surgery for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 21-25.
[5] Rui CHEN,Jieen LI. Treatment of radiation-induced carcinoma in patients with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 31-34.
[6] Wenrui XU,Yan JIANG. Surgery Treatment for Recurrent Nasopharyngeal Carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 35-38.
[7] Quan LIU,Xicai SUN,Huapeng YU,Keqing ZHAO,Huankang ZHANG,Weidong ZHAO,Yurong GU,Houyong LI,Dehui WANG,Hongmeng YU. Types of endoscopic transnasal nasopharyngectomy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 39-45.
[8] Junxiao GAO,Qianhui QIU. Efficacy of endoscopic surgery using two types of flaps to reconstruct the skull base after radiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 46-50.
[9] Lijuan ZHAO,Yan JIANG,Longgang YU,Liang CAI,Min CHEN,Jisheng ZHANG,Zhiyuan LI,Jianbao JU,Na LI. Clinical analysis of endoscopic surgery for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 51-56.
[10] Xiaohan SUN,Na LI. Introduction to the SEOM clinical guidelines for nasopharyngeal cancer (2017) [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 57-59.
[11] WANG Jun, XING Fenli, ZHU Ping, SUN Yaping, TANG Cuiju. Comparison of two nasal irrigation methods during radiotherapy in patients with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 60-63.
[12] WU Jing, LIU Yehai. Targeted therapy for head and neck squamous cell carcinoma [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 97-102.
[13] . Effects of concurrent chemotherapy and radiotherapy on the quality of life in children and adolescents with nasopharyngeal carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 55-58.
[14] LIU Ye, SUN Dianshui, YIN Jinjun, XIA Ming, XU Ying, SUN Jianhua. Vestibular function damage mechanisms in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(6): 14-17.
[15] DONG Pin, YING Xinjiang, CHEN Xinwei, DENG Zhihong, ZHANG Shaoqiang, YU Ziwei, JIN Bin, SUN Zhenfeng, XIE Jin, ZHU Jiangcai. Preliminary clinical analysis of neo-adjuvant chemotherapy with nimotuzumab plus nedaplatin and fluorouracil in hypopharyngeal squamous cell carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 10-14.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] LIN Bin,WANGHui-ge . Functional endoscopic sinus surgery, FESS[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(6): 481 -487 .
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 89 -89 .
[3] LUAN Jiangang,LIANG Chuanyu,WEN Yanjun,LI Jiong . Construction of RNAi expressing plasmid vector of pSIRENshuttle for EGFR gene silencing[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 4 -8 .
[4] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 90 -91 .
[5] LIU Da-yu,PAN Xin-liang,LEI Da-peng,ZHANG Li-qiang,LUAN Xin-yong . Surgical treatment for medial wall pyriform sinus cancer[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(1): 8 -11 .
[6] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(2): 188 -188 .
[7] MENG Qing-guo,LU Yong-tian,FAN Xian-liang .

Association of killer cell immunoglobulin-like receptor gene polymorphisms with nasopharyngeal carcinoma

[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 196 -199 .
[8] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 200 -203 .
[9] LIU Qiang-he,LUO Xiang-lin,GENG Wan-ping,CHEN Chen,LEI Xun,LIU Fang-xian,DENG Ming . Age-related spiral ganglion neuron damages and hearing loss in senescence accelerated mice[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 215 -217 .
[10] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 227 -227 .
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd